Form 4: Cencora Executive Chairman Steven Collis Executes Stock Option and Sells Shares Under 10b5-1 Plan

Steven Collis, Executive Chairman of Cencora, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 25, 2025, Steven H. Collis, Executive Chairman of Cencora, Inc., executed a transaction involving the company's common stock.
• Collis exercised non-qualified stock options to acquire 12,578 shares at a price of $86.09 per share.
• Simultaneously, Collis sold 12,578 shares at $269.51 per share and 2,000 shares at $269.51 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 25, 2024.
• Following these transactions, Collis directly owns 317,912.665 shares of Cencora common stock and 150,942 derivative securities.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It is common for executives to use Rule 10b5-1 trading plans to sell shares over time to avoid accusations of insider trading. The pharmaceutical distribution industry is highly regulated and competitive, so insider transactions are closely watched.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.
• The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

Cencora, Steven Collis, stock options, Form 4, Rule 10b5-1, insider trading, executive chairman, stock sale